title: Rabies control in the Republic of the Philippines: benefits and costs of elimination.
abstract: We compared the benefits and costs of eliminating animal and human rabies in the Philippines. If rabies had been eliminated in 1988, economic benefits would total P52.8 (US$2.5) million in 1989. These benefits would largely arise from the abolition of expenses associated with rabies prevention: P29.7 (US$1.4) million for animal vaccination, P21.6 (US$1.0) million for human postexposure prophylaxis, and P0.3 (US$0.02) million for animal rabies examinations. Benefits also included P1.2 (US$0.06) million in additional earnings of humans whose death due to rabies would be prevented. Nationwide elimination was estimated to cost between P88.1 (US$4.2) million and P317.2 (US$15.0) million, assuming a canine-to-human ratio of 1:10, vaccine coverage of 60%, and a cost per vaccination of no less than P25 (US$1.19) and no more than P90 (US$4.27). These costs would be recouped 4.1-11.0 years after the initiation of a one-year elimination campaign. A sensitivity analysis showed that an elimination programme would be economically beneficial in all but the most extreme cases.
authors.affiliation: Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, GA 30333.
authors.forename: D B
authors.initials: DB
authors.lastname: Fishbein
authors.forename: N J
authors.initials: NJ
authors.lastname: Miranda
authors.forename: P
authors.initials: P
authors.lastname: Merrill
authors.forename: R A
authors.initials: RA
authors.lastname: Camba
authors.forename: M
authors.initials: M
authors.lastname: Meltzer
authors.forename: E T
authors.initials: ET
authors.lastname: Carlos
authors.forename: C F
authors.initials: CF
authors.lastname: Bautista
authors.forename: P V
authors.initials: PV
authors.lastname: Sopungco
authors.forename: L C
authors.initials: LC
authors.lastname: Mangahas
authors.forename: L M
authors.initials: LM
authors.lastname: Hernandez
mesh_terms: D000818:Animals; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D004285:Dogs; D006801:Humans; D010679:Philippines; D011818:Rabies / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control* / Q000662:veterinary; D011819:Rabies Vaccines; D014611:Vaccination / Q000191:economics* / Q000662:veterinary
chemical_list: D011819:Rabies Vaccines